SEH/HDAC6-IN-2
SEH/HDAC6-IN-2 is a potent dual soluble epoxide hydrolase (sEH) and HDAC6 inhibitor with IC50s of 0.9 nM, 46.8 nM, and 8 nM for human sEH, mouse sEH, and HDAC6, respectively. sEH/HDAC6-IN-2 can be used for the study of inflammatory pain[1].
Product Specifications
CAS Number
3009011-58-6
UNSPSC
12352005
Target
Epoxide Hydrolase; HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/seh-hdac6-in-2.html
Smiles
O=C([C@@H]1CN(C(C2=CC=C(NC(NC3=CC=C(Cl)C(F)=C3)=O)C(F)=C2)=O)CCC1)NCCCCCCC(NO)=O
Molecular Formula
C27H32ClF2N5O5
Molecular Weight
580.02
References & Citations
[1]Huashen Xu , et al. Design and Synthesis of sEH/HDAC6 Dual-Targeting Inhibitors for the Treatment of Inflammatory Pain. J Med Chem. 2024 Jul 21.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC1; HDAC11; HDAC2; HDAC3; HDAC6; HDAC8
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MUC16 / CA125 (Ovarian Carcinoma Marker) (500000000000), CF568 conjugate, 0.1mg/mL
